Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated VRTX
$ 397.0 0.09%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

Vertex Pharmaceuticals Incorporated Long Term Debt 2011-2024 | VRTX

Annual Long Term Debt Vertex Pharmaceuticals Incorporated

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
376 M 431 M 510 M - - - - 297 M 224 M 281 M - 400 M 400 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
510 M 224 M 365 M

Quarterly Long Term Debt Vertex Pharmaceuticals Incorporated

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
114 M 347 M 362 M 376 M 390 M 404 M 418 M 431 M 442 M - 496 M 510 M 513 M 525 M 530 M 539 M 539 M 539 M 539 M 539 M 539 M 539 M 539 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 105 M 105 M 105 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
539 M 105 M 419 M